Akèy › Skleroz Miltip › Massachusetts
Etid klinik pou Skleroz Miltip nan Massachusetts
18 etid pou Skleroz Miltip ap chèche patisipan nan sit nan Massachusetts.
Vil nan Massachusetts
Tèks ofisyèl etid la (Anglè)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Boston
- TG Therapeutics Investigational Trial Site, Burlington
- TG Therapeutics Investigational Trial Site, Norfolk
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06433752RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Dana Farber Cancer Institute, Boston
- University of Massachusetts Chan Medical Center, Worcester
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Neurology Center of New England, Foxborough
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06782490A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Neuro Institute of New England P C, Foxborough
- Elliot Lewis MS Center, Wellesley
- U Mass Memorial Medical Center, Worchester
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07225504Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
- MGH Institute of Health Professions, Boston
Ap rekriteFaz 3
Laj 25 a 75 · Tout sèks · Mizajou Jul 20, 2026 · NCT06136728Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis
- Beth Israel Deaconess Medical Center, Boston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 11, 2026 · NCT04603196Care in Multiple Sclerosis (MS)
- Massachusetts General Hospital, Boston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT07011914Molecular Imaging of NET Using [C-11]MRB-PET in MS
- Brigham MS Center, 60 Fenwood Road, Boston
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Feb 2, 2026 · NCT03207464PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
- Brigham MS Center, 60 Fenwood Road, Boston
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 85 · Tout sèks · Mizajou Jan 28, 2026 · NCT02649985Glucose Consumption in MS Using [F-18]FDG-PET
- Brigham & Women's Hospital, Boston
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Jan 9, 2026 · NCT07087106Assessment of Synaptic Density in MS
- Brigham and Women's Hospital, Boston
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Jan 9, 2026 · NCT04634994Efgartigimod for the Treatment of Acute Optic Neuritis
- Massachusetts Eye and Ear Infirmary, Boston
- Massachusetts General Hospital, Boston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Nov 10, 2025 · NCT06453694Vascular Mechanisms, Functional Outcomes, & Exercise Among Persons With Multiple Sclerosis With Hypertension
- UMass Boston, Boston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 22, 2025 · NCT06554340Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis
- Brigham and Women's Hospital, Boston
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jun 6, 2025 · NCT06890923Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects
- Massachusetts General Hospital, Boston
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Feb 27, 2025 · NCT04699747IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
- Accelerated Cure Project, Waltham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Feb 18, 2025 · NCT02486562A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)
- Neurology Center of New England P.C., Foxborough
Ap rekriteEtid obsèvasyon
Laj 55 a 80 · Tout sèks · Mizajou Nov 18, 2024 · NCT06681623Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.